Do the Best Coronary Revascularization Prior TAVR

The presence of coronary artery disease (CAD) in patients with aortic stenosis is high, reaching 50% to70% of cases. This poses a great challenge as to what strategy to use and the things we can do.

Debemos hacer la mejor revasculirazión coronaria previo al TAVIEven though it has been shown complete revascularization is beneficial, it is often difficult to achieve. Instead, reasonable incomplete revascularization should have better evolution (similar to complete revascularization) than incomplete revascularization (ICR) defined as a Residual Syntax Score (rSS) >8 in TAVR. However, there is contradicting information in TAVR.

 

A meta-analysis of 3107 patients included in 6 studies was carried out, with a follow up between 0.7 and 3 years, comparing mortality amongst patients with ICR, reasonable ICR and no CAD disease.


Read also: Elderly Patients with ACS: Clopidogrel or Reduced-Dose Prasugrel?


ICR was associated to higher global mortality, compared against the rest of the groups.  The absence of CAD presented lower mortality compared to ICR (OR 1.85; 95% CI 1.42-2.240; P<0.01), reasonable ICR (OR, 1.69; 95% CI 1.26-2.28; P<0.001) or both groups combined (OR; 1.71; 95% CI, 1.36-2.16; P<0.001).

 

In reasonable ICR patients, there were no differences with those not presenting CAD (OR, 1.11; 95% CI, 0.89-1.39; P=0.33).

 

Conclusion

These outcomes suggest that in patients with coronary artery disease undergoing TAVR, guided rSS revascularization might bring significant benefits as regards mortality. Reasonable revascularization offers a precious opportunity to improve patient prognosis.

 

Commentary

These data suggest we should make an effort to obtain the best revascularization (in one or more procedures) in patients presenting significant CAD that are TAVR candidates.

 

However, note that the present indication poses a great challenge, seeing that it is about a high risk group where most patients are elderly. This involves higher risk in complex PCI, which we should perform taking special care as regards contrast volume, vascular complications and bleeding (the latter notably improved by the use of radial access).

 

Courtesy of Dr. Carlos Fava.

 

Original title: Impact of Coronary Artery Revascularization Completeness on Outcomes of patients With Coronary Artery disease Undergoing Transcatheter Aortic Valve Replacement. A Meta-analysis of Studies Using the residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).

Reference: Guy Witberg, et al . Circ cardiovasc Interv 2018;11:e006000.DOI: 10.1161.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...